ClinicalTrials.Veeva

Menu

Individualized PEEP Titration on Postoperative Pulmonary Complications

Fudan University logo

Fudan University

Status

Completed

Conditions

Laparoscopic Surgery
Postoperative Pulmonary Complications
Elderly
Positive End-expiratory Pressure

Treatments

Procedure: Pes-Guided PEEP titration

Study type

Interventional

Funder types

Other

Identifiers

NCT06150079
B2023-334R

Details and patient eligibility

About

This study aims to investigate the effectiveness and safety of implementing a personalized positive end-expiratory pressure (PEEP) management strategy guided by esophageal pressure (Pes), as well as its potential to reduce the occurrence of postoperative pulmonary complications (PPCs) in elderly patients undergoing laparoscopic surgery.

Full description

This trial is a single-blind, randomized, controlled, multicenter study. Elderly patients undergoing laparoscopic surgery under general anesthesia will be recruited according the inclusion and exclusion criteria. Participants in this study will be randomly assigned into two groups. The total sample size will be 232, with 116 participants in the experimental group and 116 participants in the control group. A stratified block randomization method will be employed, using the ARISCAT score for PPCs risk assessment and individual study centers as stratification factors. Anesthesia routine will be applied during pre-anesthetic preparation, anesthetic induction, maintenance and emergence except intraoperative respiratory management. In the control group (PEEP Group), fixed PEEP of 3 cmH2O is applied throughout the procedure without lung recruitment maneuvers. While in the experimental group (Pes-Guided PEEP Group), continuous monitoring of end-expiratory esophageal pressure (Pes_ee) is conducted. PEEP is chosen to maintain a positive transpulmonary pressure at end-expiration (Ptp_ee = PEEP - Pes_ee) after lung recruitment. PEEP titration following lung recruitment should be performed after endotracheal intubation or any procedure that may cause lung collapse, such as pneumoperitoneum, deflation or inflation of the endotracheal tube cuff, changes in position, or endotracheal suctioning. PEEP Titration is also required every hour after the establishment of pneumoperitoneum. Patients will be followed up within 7 days after surgery to assess basic vital signs, potential postoperative pulmonary complications (PPCs). Additionally, postoperative non-respiratory complications will be evaluated.Laboratory tests, the 15-item Quality of Recovery-15 (QoR-15) questionnaire, complications within 30 days after surgery, and 90-day survival rates will also be recorded.

Enrollment

240 patients

Sex

All

Ages

65+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Patients aged 65 years or older, of any gender.
  2. Laparoscopic surgery under general anesthesia.
  3. Anticipated duration of surgery ≥ 2 hours.
  4. Willingness to sign informed consent or provide a legally authorized representative.

Exclusion criteria

  1. Obesity, defined as BMI ≥ 35 kg/m2.
  2. History of pulmonary surgery (of any type).
  3. History of severe chronic obstructive pulmonary disease (COPD) requiring non-invasive ventilation and/or home oxygen therapy, or systemic corticosteroid treatment for acute COPD exacerbations.
  4. Severe pulmonary arterial hypertension, defined as pulmonary artery systolic pressure > 40 mmHg.
  5. Heart failure, ongoing hemodynamic instability, or severe shock (as determined by the attending internist), cardiac index < 2.5 L/min/m2, or the requirement for positive inotropic drugs to maintain blood pressure.
  6. Severe cardiac disease (NYHA class III or IV, acute coronary syndrome, sustained ventricular tachyarrhythmias, unable to achieve > 4 METs).
  7. Severe liver or renal dysfunction (Child-Pugh score 10-15, serum creatinine ≥ 2 mg/dL, or patients requiring peritoneal dialysis or hemodialysis).
  8. Neuromuscular disease (of any type).
  9. History of bone marrow transplantation or recent use of immunosuppressive drugs (chemotherapy or radiotherapy within 2 months before surgery).
  10. Mechanical ventilation duration > 30 minutes within the past 30 days (e.g., during surgery under general anesthesia).
  11. Requirement for one-lung ventilation.
  12. History of acute respiratory distress syndrome with potential need for prolonged postoperative mechanical ventilation.
  13. Planned re-intubation after surgery.
  14. Pregnancy (excluded by medical history and/or laboratory tests).
  15. Brain injury or tumor.
  16. Requirement for prone or lateral position during surgery.
  17. Severe esophagogastric varices.
  18. Enrollment in other interventional studies or refusal to sign informed consent.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

240 participants in 2 patient groups

PEEP Group
No Intervention group
Description:
After endotracheal intubation, an esophageal balloon is placed and calibrated for accurate positioning and inflation pressure. Continuous monitoring of end-expiratory esophageal pressure (Pes_ee) is conducted. Fixed PEEP of 3 cmH2O is applied throughout the procedure without lung recruitment maneuvers.
Pes-Guided PEEP Group (PEEPPtp)
Experimental group
Description:
After endotracheal intubation, an esophageal balloon is placed and calibrated for accurate positioning and inflation pressure. Continuous monitoring of end-expiratory esophageal pressure (Pes_ee) is conducted. Lung recruitment is performed at each time point. After lung recruitment, ventilation is adjusted based on the target PEEP. PEEP is chosen to maintain a positive transpulmonary pressure at end-expiration (Ptp_ee = PEEP - Pes_ee). PEEP titration following lung recruitment should be performed within 1 hour after endotracheal intubation or any procedure that may cause lung collapse, such as pneumoperitoneum, deflation or inflation of the endotracheal tube cuff, changes in position, or endotracheal suctioning.
Treatment:
Procedure: Pes-Guided PEEP titration

Trial contacts and locations

4

Loading...

Central trial contact

Jing Zhong; Changhong Miao

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems